Latest filing published 28 Oct 2010 for Trubion Pharmaceuticals, Inc.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
David A. Mann discloses dealings in Trubion Pharmaceuticals, Inc to SEC (Form 4). In total, 12 filings cover trades dated from 29 November 2006 to 28 October 2010.
No open-market sale appears; the market trades are 11 purchases worth €108k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €4,119.
The newest entry dates from 28 October 2010: a transaction, in Trubion Pharmaceuticals, Inc. The last insider purchase was made public on 5 September 2008, 6,622 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations